CA Healthcare Acquisition Corp. (NASDAQ:CAHCW) operates as a blank check company whose sole purpose is to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities, with a focus on the healthcare industry including healthcare services; healthcare information technology; care management; behavioral health; medical devices; diagnostics; pharma services; health and wellness; and specialty pharmacy. Founded in 2020 and headquartered at 99 Summer Street, Suite 200, Boston, Massachusetts, the company went public via an initial public offering on March 9, 2021, raising $100 million, and its warrants (CAHCW) are exercisable into common shares expiring December 25, 2025. In September 2021, it completed a merger with LumiraDx Limited, a UK-based next-generation point-of-care diagnostics company, valuing LumiraDx at $3.0 billion enterprise value (excluding IPO proceeds); post-merger, LumiraDx common shares traded under LMDX and warrants under LMDXW on Nasdaq, while CAHCW warrants from the SPAC continue to trade separately with no reported further business combinations, funding rounds, acquisitions, or operational changes as of late 2025. The company maintains a small team of 2-10 employees and targets global healthcare opportunities without current significant operations beyond seeking such transactions.